Seroprevalence of Rubella Virus Antibodies and Antibody Titer Among Childbearing Aged Women
Journal of The Best Available Evidence in Medicine · 2025
DOI: 10.63720/hb7id669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Best Available Evidence in Medicine, 2025. Verfasst von Yasmin Haleem Alferjani und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Health threat, particularly to women of childbearing age. Maternal rubella infection, especially during the first trimester of pregnancy can lead to congenital rubella syndrome resulting in severe birth defects including deafness, cardiac disease, intellectual disability, and ocular conditions. Despite the significant decline of cases globally, rubella remains a global health concern, especially in regions such as Africa, East Asia, and South Asia. The aim of this research is to provide new data for the sero-prevalence of rubella antibodies and antibody titers among childbearing aged women studying or working at the Libyan International University, and to assess the need for a booster dose of MMR vaccine.
Zitieren
APA
Alferjani, Y. H., Aldanini, T. F., & Mansur, K. M. H. (2025). Seroprevalence of Rubella Virus Antibodies and Antibody Titer Among Childbearing Aged Women. Journal of The Best Available Evidence in Medicine. https://doi.org/10.63720/hb7id669
Vancouver
Alferjani YH, Aldanini TF, Mansur KMH. Seroprevalence of Rubella Virus Antibodies and Antibody Titer Among Childbearing Aged Women. Journal of The Best Available Evidence in Medicine. 2025. doi:10.63720/hb7id669
BibTeX
@article{Alferjani2025,
author = {Alferjani, Yasmin Haleem and Aldanini, Thuraya Faisal and Mansur, Khadija Muftah Hilal},
title = {Seroprevalence of Rubella Virus Antibodies and Antibody Titer Among Childbearing Aged Women},
journal = {Journal of The Best Available Evidence in Medicine},
year = {2025},
doi = {10.63720/hb7id669}
}
EUVIMED